Year |
Citation |
Score |
2020 |
Chakroborty S, Manfredsson FP, Dec AM, Campbell PW, Stutzmann GE, Beaumont V, West AR. Phosphodiesterase 9A Inhibition Facilitates Corticostriatal Transmission in Wild-Type and Transgenic Rats That Model Huntington's Disease. Frontiers in Neuroscience. 14: 466. PMID 32581668 DOI: 10.3389/Fnins.2020.00466 |
0.323 |
|
2019 |
Chakroborty S, Hill ES, Christian DT, Helfrich R, Riley S, Schneider C, Kapecki N, Mustaly-Kalimi S, Seiler FA, Peterson DA, West AR, Vertel BM, Frost WN, Stutzmann GE. Reduced presynaptic vesicle stores mediate cellular and network plasticity defects in an early-stage mouse model of Alzheimer's disease. Molecular Neurodegeneration. 14: 7. PMID 30670054 DOI: 10.1186/S13024-019-0307-7 |
0.49 |
|
2019 |
Refolo LM, Chakroborty S, Martin Z, Sheffield C, Petanceska SS. P4-075: Alzped: A New Data Resource For Improving The Rigor, Transparency, Reproducibility And Translation Of Alzheimer'S Disease Preclinical Research Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.3735 |
0.305 |
|
2017 |
Lacampagne A, Liu X, Reiken S, Bussiere R, Meli AC, Lauritzen I, Teich AF, Zalk R, Saint N, Arancio O, Bauer C, Duprat F, Briggs CA, Chakroborty S, Stutzmann GE, et al. Post-translational remodeling of ryanodine receptor induces calcium leak leading to Alzheimer's disease-like pathologies and cognitive deficits. Acta Neuropathologica. PMID 28631094 DOI: 10.1007/S00401-017-1733-7 |
0.515 |
|
2016 |
Beaumont V, Zhong S, Lin H, Xu W, Bradaia A, Steidl E, Gleyzes M, Wadel K, Buisson B, Padovan-Neto FE, Chakroborty S, Ward KM, Harms JF, Beltran J, Kwan M, et al. Phosphodiesterase 10A Inhibition Improves Cortico-Basal Ganglia Function in Huntington's Disease Models. Neuron. PMID 27916455 DOI: 10.1016/J.Neuron.2016.10.064 |
0.319 |
|
2016 |
Briggs CA, Chakroborty S, Stutzmann GE. Emerging pathways driving early synaptic pathology in Alzheimer's disease. Biochemical and Biophysical Research Communications. PMID 27659710 DOI: 10.1016/J.Bbrc.2016.09.088 |
0.524 |
|
2015 |
Chakroborty S, Kim J, Schneider C, West AR, Stutzmann GE. Nitric oxide signaling is recruited as a compensatory mechanism for sustaining synaptic plasticity in Alzheimer's disease mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 6893-902. PMID 25926464 DOI: 10.1523/Jneurosci.4002-14.2015 |
0.528 |
|
2015 |
Padovan-Neto FE, Sammut S, Chakroborty S, Dec AM, Threlfell S, Campbell PW, Mudrakola V, Harms JF, Schmidt CJ, West AR. Facilitation of corticostriatal transmission following pharmacological inhibition of striatal phosphodiesterase 10A: role of nitric oxide-soluble guanylyl cyclase-cGMP signaling pathways. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 5781-91. PMID 25855188 DOI: 10.1523/Jneurosci.1238-14.2015 |
0.324 |
|
2014 |
Chakroborty S, Stutzmann GE. Calcium channelopathies and Alzheimer's disease: insight into therapeutic success and failures. European Journal of Pharmacology. 739: 83-95. PMID 24316360 DOI: 10.1016/J.Ejphar.2013.11.012 |
0.466 |
|
2012 |
Chakroborty S, Briggs C, Miller MB, Goussakov I, Schneider C, Kim J, Wicks J, Richardson JC, Conklin V, Cameransi BG, Stutzmann GE. Stabilizing ER Ca2+ channel function as an early preventative strategy for Alzheimer's disease. Plos One. 7: e52056. PMID 23284867 DOI: 10.1371/Journal.Pone.0052056 |
0.522 |
|
2012 |
Chakroborty S, Kim J, Schneider C, Jacobson C, Molgó J, Stutzmann GE. Early presynaptic and postsynaptic calcium signaling abnormalities mask underlying synaptic depression in presymptomatic Alzheimer's disease mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 8341-53. PMID 22699914 DOI: 10.1523/Jneurosci.0936-12.2012 |
0.539 |
|
2011 |
Chakroborty S, Stutzmann GE. Early calcium dysregulation in Alzheimer's disease: setting the stage for synaptic dysfunction. Science China. Life Sciences. 54: 752-62. PMID 21786198 DOI: 10.1007/S11427-011-4205-7 |
0.529 |
|
2011 |
Goussakov I, Chakroborty S, Stutzmann GE. Generation of dendritic Ca2+ oscillations as a consequence of altered ryanodine receptor function in AD neurons. Channels (Austin, Tex.). 5: 9-13. PMID 21139422 DOI: 10.4161/Chan.5.1.14124 |
0.469 |
|
2011 |
Goussakov I, Chakroborty S, Stutzmann GE. Generation of dendritic Ca 2+ oscillations as a consequence of altered ryanodine receptor function in AD neurons Channels. 5: 9-13. |
0.31 |
|
2010 |
Stutzmann GE, Chakroborty S, Goussakov I, Miller M. P2-335: Neuronal signaling mechanisms underlying synaptic deficits in Alzheimer's Alzheimer's & Dementia. 6: S411-S412. DOI: 10.1016/J.Jalz.2010.05.1386 |
0.425 |
|
2009 |
Chakroborty S, Goussakov I, Miller MB, Stutzmann GE. Deviant ryanodine receptor-mediated calcium release resets synaptic homeostasis in presymptomatic 3xTg-AD mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 9458-70. PMID 19641109 DOI: 10.1523/Jneurosci.2047-09.2009 |
0.546 |
|
2009 |
Atwood C, Bacskai B, Kuchibhotla K, Bezprozvanny I, Chakroborty S, Fagan T, Foskett K, Green K, Goussakov I, Moyer J, Michno K, Rybalchenko V, Stutzmann B, Villalobos C. Alzheimer research forum live discussion: Calcium in AD pathogenesis Journal of Alzheimer's Disease. 16: 909-917. PMID 19387122 DOI: 10.3233/Jad-2009-1026 |
0.423 |
|
2008 |
Chakroborty S, Goussakov I, Aumiller B, Huang JY, Stutzmann GE. P4-271: Relative contribution of ER calcium channels to synaptic activity and plasticity in mutant PS1 Alzheimer's disease mouse models Alzheimer's & Dementia. 4: T750-T751. DOI: 10.1016/J.Jalz.2008.05.2340 |
0.44 |
|
Show low-probability matches. |